The randomized nitric oxide tocolysis trial (RNOTT) for the treatment of preterm labor - 25/08/11

Résumé |
Objective |
This study was undertaken to assess the effectiveness of glyceryl trinitrate (GTN) patches in comparison with β2 sympathomimetics (β2) for the treatment of preterm labor.
Study design |
A multicenter, multinational, randomized controlled trial was conducted in tertiary referral teaching hospitals. Women in threatened preterm labor with positive fetal fibronectin or ruptured membranes between 24 and 35 weeks' gestation were recruited and randomly assigned to either β2 or GTN with rescue β2 tocolysis if moderate-to-strong contractions persisted at 2 hours. Obstetric and neonatal outcomes were assessed.
Results |
Two hundred thity-eight women were recruited and randomly assigned, 117 to β2 and 121 to GTN. On a strict intention-to-treat basis, there was no significant difference in the time to delivery using Kaplan-Meier curves (P=.451). At 2 hours, 27% of women receiving β2 had moderate or stronger contractions compared with 53% in the GTN group (P < .001). This led to 35% of women in the GTN group receiving rescue treatment. If delivery or requirement for β2 rescue are regarded as treatment failure, then a significant difference was observed between the 2 arms (P=.0032). There were no significant differences in neonatal outcomes.
Conclusion |
GTN is a less efficacious tocolytic compared with ß2 sympathomimetics.
Le texte complet de cet article est disponible en PDF.Key words : Nitric oxide, Randomized controlled trial, Tocolysis
Plan
| Supported by the National Health and Medical Research Council of Australia (GN ID 9937359) and Commonwealth Government of Australia Targeted Institutional Links Grant Programme. |
Vol 191 - N° 3
P. 683-690 - septembre 2004 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
